Terms: = Skin cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Clinical Outcome
254 results:
1. Whole exome germline sequencing in early-onset prostate cancer patients: Genomic findings and clinical outcomes.
Siegelmann-Danieli N; Neiman V; Bareket-Samish A; Berger R; Peretz A; Alapi H; Tsur E; Patalon T; Beller D; Rimler G; Chodick G; Shohat M
Prostate; 2024 Jan; 84(1):39-46. PubMed ID: 37842866
[TBL] [Abstract] [Full Text] [Related]
2. Association of clinical manifestations of secondary lymphedema and lymph node dissection sites in the lower extremities of patients with melanoma.
Chae Woon P; Kim I; Kim JH; Hwang JH
Acta Oncol; 2023 Aug; 62(8):880-888. PubMed ID: 37656769
[TBL] [Abstract] [Full Text] [Related]
3. Molecular Features of Resected Melanoma Brain Metastases, clinical outcomes, and Responses to Immunotherapy.
Vasudevan HN; Delley C; Chen WC; Mirchia K; Pan S; Shukla P; Aabedi AA; Nguyen MP; Morshed RA; Young JS; Boreta L; Fogh SE; Nakamura JL; Theodosopoulos PV; Phillips J; Hervey-Jumper SL; Daras M; Pike L; Aghi MK; Tsai K; Raleigh DR; Braunstein SE; Abate AR
JAMA Netw Open; 2023 Aug; 6(8):e2329186. PubMed ID: 37589977
[TBL] [Abstract] [Full Text] [Related]
4. Effect of lidocaine spray on reliving non-coring needle puncture-related pain in patients with totally implantable venous access port: a randomized controlled trial.
Zhu Y; Niu S; Zhang Y; Zhang H; Chang J; Ye L
Support Care Cancer; 2023 Jul; 31(8):452. PubMed ID: 37421451
[TBL] [Abstract] [Full Text] [Related]
5. BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors.
Mandalà M; Palmieri G; Ludovini V; Baglivo S; Marasciulo F; Castiglione F; Gili A; Osella Abate S; Rubatto M; Senetta R; Avallone G; Ribero S; Romano L; Pimpinelli N; de Giorgi V; Roila F; Pisano M; Casula M; Manca A; Sini MC; Massi D; Quaglino P;
J Eur Acad Dermatol Venereol; 2023 Oct; 37(10):1991-1998. PubMed ID: 37335879
[TBL] [Abstract] [Full Text] [Related]
6. A nanotherapeutic strategy that engages cytotoxic and immunosuppressive activities for the treatment of cancer recurrence following organ transplantation.
Yang Z; Xie H; Wan J; Wang Y; Zhang L; Zhou K; Tang H; Zhao W; Wang H; Song P; Zheng S
EBioMedicine; 2023 Jun; 92():104594. PubMed ID: 37167784
[TBL] [Abstract] [Full Text] [Related]
7. Cognitive functional therapy with or without movement sensor biofeedback versus usual care for chronic, disabling low back pain (RESTORE): a randomised, controlled, three-arm, parallel group, phase 3, clinical trial.
Kent P; Haines T; O'Sullivan P; Smith A; Campbell A; Schutze R; Attwell S; Caneiro JP; Laird R; O'Sullivan K; McGregor A; Hartvigsen J; Lee DA; Vickery A; Hancock M;
Lancet; 2023 Jun; 401(10391):1866-1877. PubMed ID: 37146623
[TBL] [Abstract] [Full Text] [Related]
8. Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution.
Garcia-Donas J; Martínez-Urbistondo D; Velázquez Kennedy K; Villares P; Barquin A; Dominguez A; Rodriguez-Moreno JF; Caro E; Suarez Del Villar R; Nistal-Villan E; Yagüe M; Ortiz M; Barba M; Ruiz-Llorente S; Quiralte M; Zanin M; Rodríguez C; Navarro P; Berraondo P; Madurga R
Front Immunol; 2023; 14():1156603. PubMed ID: 37143685
[TBL] [Abstract] [Full Text] [Related]
9. Predictive value and accuracy of [
Ayati N; Jamshidi-Araghi Z; Hoellwerth M; Schweighofer-Zwink G; Hitzl W; Koelblinger P; Pirich C; Beheshti M
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2715-2726. PubMed ID: 37140669
[TBL] [Abstract] [Full Text] [Related]
10. Type 2 Diabetes Mellitus and Efficacy outcomes from Immune Checkpoint Blockade in Patients with cancer.
Cortellini A; D'Alessio A; Cleary S; Buti S; Bersanelli M; Bordi P; Tonini G; Vincenzi B; Tucci M; Russo A; Pantano F; Russano M; Stucci LS; Sergi MC; Falconi M; Zarzana MA; Santini D; Spagnolo F; Tanda ET; Rastelli F; Giorgi FC; Pergolesi F; Giusti R; Filetti M; Lo Bianco F; Marchetti P; Botticelli A; Gelibter A; Siringo M; Ferrari M; Marconcini R; Vitale MG; Nicolardi L; Chiari R; Ghidini M; Nigro O; Grossi F; De Tursi M; Di Marino P; Queirolo P; Bracarda S; Macrini S; Inno A; Zoratto F; Veltri E; Spoto C; Vitale MG; Cannita K; Gennari A; Morganstein DL; Mallardo D; Nibid L; Sabarese G; Brunetti L; Perrone G; Ascierto PA; Ficorella C; Pinato DJ
Clin Cancer Res; 2023 Jul; 29(14):2714-2724. PubMed ID: 37125965
[TBL] [Abstract] [Full Text] [Related]
11. Real-world clinical outcome and safety of adjuvant therapy in stage III melanoma patients: Data from two Academic Italian Institutions.
De Falco V; Suarato G; Napolitano R; Argenziano G; Famiglietti V; Amato A; Servetto A; Bianco R; Formisano L; Terrano V; Esposito A; Giugliano MC; Ciardiello D; Ciardiello F; Napolitano S; Troiani T
Int J Cancer; 2023 Jul; 153(1):133-140. PubMed ID: 36752579
[TBL] [Abstract] [Full Text] [Related]
12. outcomes of feeding jejunostomy after pancreaticoduodenectomy: A single-center experience.
Yamamoto N; Aoyama T; Murakawa M; Kamiya M; Shiozawa M; Rino Y; Masuda M; Morinaga S
J Cancer Res Ther; 2022 Dec; 18(Supplement):S444-S448. PubMed ID: 36511001
[TBL] [Abstract] [Full Text] [Related]
13. Characterization and dynamics of the soluble immunological microenvironment in melanoma patients undergoing radiotherapy.
Oertel M; Borrmann K; Baehr A; Eich HT; Greve B
Radiat Oncol; 2022 Nov; 17(1):194. PubMed ID: 36443849
[TBL] [Abstract] [Full Text] [Related]
14. Ambiguous melanocytic lesions: A retrospective cohort study of incidence and outcome of melanocytic tumor of uncertain malignant potential (MELTUMP) and superficial atypical melanocytic proliferation of uncertain significance (SAMPUS) in the Netherlands.
Vermariën-Wang J; Doeleman T; van Doorn R; Mooyaart AL; Blokx WAM; Schrader AMR
J Am Acad Dermatol; 2023 Mar; 88(3):602-608. PubMed ID: 36403750
[TBL] [Abstract] [Full Text] [Related]
15. The Feasibility of Immunocryosurgery in the Treatment of Non-Superficial, Facial Basal Cell Carcinoma That Relapsed after Standard Surgical Excision: An Experience Report from Two Centers.
Gaitanis G; Zampeta A; Tsintzou P; Fillis G; Seretis K; Feldmeyer L; Bassukas I
Curr Oncol; 2022 Nov; 29(11):8475-8482. PubMed ID: 36354728
[TBL] [Abstract] [Full Text] [Related]
16. clinical management of melanocytic tumours of uncertain malignant potential (MelTUMPs), including melanocytomas: A systematic review and meta-analysis.
Varey AHR; Williams GJ; Lo SN; Taing CY; Maurichi A; Santinami M; Scolyer RA; Thompson JF
J Eur Acad Dermatol Venereol; 2023 May; 37(5):859-870. PubMed ID: 36251355
[TBL] [Abstract] [Full Text] [Related]
17. Cigarette smoking and adverse health outcomes in patients treated with maintenance dialysis.
Bek SG; Marschner S; Sud K; Johnson DW; Chow CK; Hawley C; Pilmore H; Wong G; Lim W; Lee VW
Nephrology (Carlton); 2023 Jan; 28(1):21-27. PubMed ID: 36222366
[TBL] [Abstract] [Full Text] [Related]
18. Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study.
Kemps PG; Zondag TCE; Arnardóttir HB; Solleveld-Westerink N; Borst J; Steenwijk EC; van Egmond D; Swennenhuis JF; Stelloo E; Trambusti I; Verdijk RM; van Noesel CJM; Cleven AHG; Scheijde-Vermeulen MA; Koudijs MJ; Krsková L; Hawkins C; Egeler RM; Brok J; von Bahr Greenwood T; Svojgr K; Beishuizen A; van Laar JAM; Pötschger U; Hutter C; Sieni E; Minkov M; Abla O; van Wezel T; van den Bos C; van Halteren AGS
Blood Adv; 2023 Feb; 7(4):664-679. PubMed ID: 36083130
[TBL] [Abstract] [Full Text] [Related]
19. A cohort analysis of surgically treated primary head and neck lentigo maligna (melanoma): Prognostic value of melanoma subtype and new insights in the clinical value of guideline adherence.
Elshot YS; Zupan-Kajcovski B; Ouwerkerk W; Klop WMC; Lohuis PJFM; Bol M; Crijns MB; Bekkenk MW; de Rie MA; Balm AJM
Eur J Surg Oncol; 2023 Apr; 49(4):818-824. PubMed ID: 36031471
[TBL] [Abstract] [Full Text] [Related]
20. Malignancy Diseases in Kidney Transplantation, clinical outcomes, Patient, and Allograft Survival: A Case-Control Study.
Pinto-Filho VA; Nascimento E; Cunha APL; Assis BPS; Lasmar MF; Vianna HR; Fabreti-Oliveira RA
Transplant Proc; 2022 Jun; 54(5):1253-1261. PubMed ID: 35750515
[TBL] [Abstract] [Full Text] [Related]
[Next]
